Medicamen Biotech Limited (BSE: 531146)
Health Care · Pharmaceuticals · IN
Rs246.10
+2.22% today · -29.6% 1Y
Medicamen Biotech Limited (BSE: 531146) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $32.70M.
Over the last twelve months the share price has lost 29.6%, trading between 210.10 and 454.00.
Tweenvest scores Medicamen Biotech Limited across four factors: quality 67/100, value 69/100, growth 38/100, dividend 39/100. Its strongest factor is value.
531146 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $32.70M
- Revenue (TTM)
- $21.80M
- P/E
- 33.04
- EPS
- 7.45
- Dividend yield
- 0.41%
- Beta (5Y)
- 0.72
- 52-week high
- Rs454.00
- 52-week low
- Rs210.10
- Avg volume (3M)
- —
- Shares outstanding
- 12.71M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,233.66 | -1.06% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.14 | +0.04% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $156.45 | +3.84% |
| Roche Holding AGSWX: ROP | $371.62B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.57 | +2.15% |
Figures last refreshed Aug 18, 2026.